Toll-like receptor 3 and interleukin 1ß expression in CD34+ cells from patients with rheumatoid arthritis: Association with inflammation and vascular involvement

Clinical and Experimental Rheumatology

Volumn 32, Issue 6, 2014, Pages 922-929

  Lo Gullo, Alberto ^a   Mandraffino, Giuseppe ^a   Imbalzano, Egidio ^a   Mamone, Federica ^a   Aragona, Caterina O ^a   D'Ascola, Angela ^b   Loddo, Saverio ^b   Cinquegrani, Antonella ^a   Alibrandi, Angela ^b   Mormina, Enricomaria ^b   Bagnato, Gian Filippo ^a   Lo Gullo, Renato ^a   Sardo, Maria A ^a   Saitta, Antonino ^a  

^a UNIVERSITY OF MESSINA   (Italy)

^b UNIVERSITY OF MESSINA   (Italy)

Author keywords

Arterial stiffness; Circulating progenitor cells; Interleukin 1 ; Preclinical atherosclerosis; Rheumatoid arthritis; Toll like receptor 3

Indexed keywords

C REACTIVE PROTEIN; FIBRINOGEN; INTERLEUKIN 1BETA; REACTIVE OXYGEN METABOLITE; TOLL LIKE RECEPTOR 3; AUTACOID; BIOLOGICAL MARKER; CD34 ANTIGEN; IL1B PROTEIN, HUMAN; TLR3 PROTEIN, HUMAN;

ADULT; ARTERIAL STIFFNESS; ARTERIAL WALL THICKNESS; ARTICLE; ATHEROSCLEROSIS; AUGMENTATION INDEX; BLOOD VESSEL INJURY; CD34 SELECTION; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PULSE WAVE; RETROSPECTIVE STUDY; RHEUMATOID ARTHRITIS; ARTHRITIS, RHEUMATOID; BLOOD; CASE CONTROL STUDY; CROSS-SECTIONAL STUDY; ENDOTHELIUM CELL; HEMATOPOIETIC STEM CELL; IMMUNOLOGY; INFLAMMATION; METABOLISM; MIDDLE AGED; RISK FACTOR; UPREGULATION;

ADULT; ANTIGENS, CD34; ARTHRITIS, RHEUMATOID; ATHEROSCLEROSIS; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CAROTID INTIMA-MEDIA THICKNESS; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; ENDOTHELIAL CELLS; FEMALE; HEMATOPOIETIC STEM CELLS; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; INTERLEUKIN-1BETA; MALE; MIDDLE AGED; REACTIVE OXYGEN SPECIES; RISK FACTORS; TOLL-LIKE RECEPTOR 3; UP-REGULATION; VASCULAR STIFFNESS;

EID: 84925285049     PISSN: 0392856X     EISSN: 1593098X     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. YAMAGUCHI Y, KUWANA M: Proangiogenic hematopoietic cells of monocytic origin: roles in vascular regeneration and pathogenic processes of systemic sclerosis. Histol Histopathol 2013; 28: 175-83.
2. RICHARDSON MR, YODER MC: Endothelial progenitor cells: quo vadis? J Mol Cell Cardiol 2011; 50: 266-72.
3. STEINMETZ M, NICKENIG G, WERNER N: Endothelial-regenerating cells: an expanding universe. Hypertension 2010; 55: 593-9.
4. + cells after immobilization on activated platelets. Arterioscler Thromb Vasc Biol 2011; 31: 408-15.
5. Di STEFANO R, FELICE F, FERIANI R, BALBARINI A: Endothelial progenitor cells, cardiovascular risk factors and lifestyle modifications. Intern Emerg Med 2013; 8 (Suppl. 1): S47-9.
6. WERNER N, KOSIOL S, SCHIEGL T et al.: Circulating endothelial progenitor cells and cardiovascular outcomes. N Engl J Med 2005; 353: 999-1007.
7. HILL JM, ZALOS G, HALCOX JP et al.: Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med 2003; 348: 593-600.
8. MANDRAFFINO G, SARDO MA, RIGGIO S et al.: Circulating progenitor cells and the elderly: a seven-year observational study. Exp Gerontol 2012; 47: 394-400.
9. WARRINGTON KJ, KENT PD, FRYE RL et al.: Rheumatoid arthritis is an independent risk factor for multi-vessel coronary artery disease: a case control study. Arthritis Res Ther 2005; 7: R984-91.
10. MEUNE C, TOUZE E, TRINQUART L, ALLANORE Y: Trends in cardiovascular mortality in patients with rheumatoid arthritis over 50 years: a systematic review and meta-analysis of cohort studies. Rheumatology (Oxford) 2009; 48: 1309-13.
11. KU IA, IMBODEN JB, HSUE PY, GANZ P: Rheumatoid arthritis: model of systemic inflammation driving atherosclerosis. Circ J 2009; 73: 977-85.
12. SATTAR N, McCAREY DW, CAPELL H, McINNES IB: Explaining how "high-grade" systemic inflammation accelerates vascular risk in rheumatoid arthritis. Circulation 2003; 108: 2957-63.
13. SILVERMAN MD, HAAS CS, RAD AM, ARBAB AS, KOCH AE: The role of vascular cell adhesion molecule 1/very late activation antigen 4 in endothelial progenitor cell recruitment to rheumatoid arthritis synovium. Arthritis Rheum 2007; 56: 1817-26.
14. HERBRIG K, HAENSEL S, OELSCHLAEGEL U, PISTROSCH F, FOERSTER S, PASSAUER J: Endothelial dysfunction in patients with rheumatoid arthritis is associated with a reduced number and impaired function of endothelial progenitor cells. Ann Rheum Dis 2006; 65: 157-63.
15. GRISAR J, ALETAHA D, STEINER CW et al.: Depletion of endothelial progenitor cells in the peripheral blood of patients with rheumatoid arthritis. Circulation 2005; 111: 204-11.
16. WESTERWEEL PE, VERHAAR MC: Endothelial progenitor cell dysfunction in rheumatic disease. Nat Rev Rheumatol 2009; 5: 332-40.
17. LO GULLO A, MANDRAFFINO G, SARDO M et al.: Circulating progenitor cells in rheumatoid arthritis: association with inflammation and oxidative stress. Scand J Rheumatol 2014; 43: 184-93.
18. ALEXOPOULOU L, HOLT AC, MEDZHITOV R, FLAVELL RA: Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3. Nature 2001; 413: 732-8.
19. MONACO C, TERRANDO N, MIDWOOD KS: Toll-like receptor signaling: common pathways that drive cardiovascular disease and rheumatoid arthritis. Arthritis Care Res (Hoboken) 2011; 63: 500-11.
20. YANG M, XIAO Z, LV Q et al.: The functional expression of TLR3 in EPCs impairs cell proliferation by induction of cell apoptosis and cell cycle progress inhibition. Int Immunopharmacol 2011; 11: 2118-24.
21. MARTINON F, TSCHOPP J: Inflammatory caspases and inflammasomes: master switches of inflammation. Cell Death Differ 2007; 14: 10-22.
22. GABAY C, LAMACCHIA C, PALMER G: IL-1 pathways in inflammation and human diseases. Nat Rev Rheumatol 2010; 6: 232-41.
23. MAELFAIT J, VERCAMMEN E, JANSSENS S et al.: Stimulation of Toll-like receptor 3 and 4 induces interleukin-1beta maturation by caspase-8. J Exp Med 2008 Sep; 205: 1967-73.
24. ZIMMER S, STEINMETZ M, ASDONK T et al.: Activation of endothelial toll-like receptor 3 impairs endothelial function. Circ Res 2011; 108: 1358-66.
25. GRELIER A, CRAS A, BALITRAND N et al.: Toll-like receptor 3 regulates cord bloodderived endothelial cell function in vitro and in vivo. Angiogenesis 2013; 16: 821-36.
26. PROVAN SA, ANGEL K, SEMB AG et al.: Early prediction of increased arterial stiffness in patients with chronic inflammation: a 15-year followup study of 108 patients with rheumatoid arthritis. J Rheumatol 2011; 38: 606-12.
27. ARNETT FC, EDWORTHY SM, BLOCH DA et al.: The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315-24.
28. MANDRAFFINO G, SARDO MA, RIGGIO S et al.: Circulating progenitor cells are increased in newly diagnosed untreated hypertensive patients with arterial stiffening but normal carotid intima-media thickness. Hypertens Res 2011; 34: 876-83.
29. LeBEL CP, ISCHIROPOULOS H, BONDY SC: Evaluation of the probe 2',7'-dichlorofluorescin as an indicator of reactive oxygen species formation and oxidative stress. Chem Res Toxicol 1992; 5: 227-31.
30. RIGGIO S, MANDRAFFINO G, SARDO MA et al.: Pulse wave velocity and augmentation index, but not intima-media thickness, are early indicators of vascular damage in hypercholesterolemic children. Eur J Clin Invest 2010; 40: 250-7.
31. PESARIN F, SALMASO L: Permutation Tests for Complex Data: Theory, Applications and Software, Chichester, Wiley, 2010.
32. PESARIN F (Ed.): Multivariate Permutation Tests with Applications in Biostatistics, Chichester, Wiley, 2001.
33. MANCIA G, De BACKER G, DOMINICZAK A et al.: 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2007; 25: 1105-87.
34. FADINI GP, de KREUTZENBERG S, AGOSTINI C et al.: Low CD34+ cell count and metabolic syndrome synergistically increase the risk of adverse outcomes. Atherosclerosis 2009; 207: 213-9.
35. PESCE M, BURBA I, GAMBINI E, PRANDI F, POMPILIO G, CAPOGROSSI MC: Endothelial and cardiac progenitors: boosting, conditioning and (re)programming for cardiovascular repair. Pharmacol Ther 2011; 129: 50-61.
36. HIRSCHI KK, INGRAM DA, YODER MC: Assessing identity, phenotype, and fate of endothelial progenitor cells. Arterioscler Thromb Vasc Biol 2008; 28: 1584-95.
37. REYES M, DUDEK A, JAHAGIRDAR B, KOODIE L, MARKER PH, VERFAILLIE CM: Origin of endothelial progenitors in human postnatal bone marrow. J Clin Invest 2002; 109: 337-46.
38. FADINI GP, MARUYAMA S, OZAKI T et al.: Circulating progenitor cell count for cardiovascular risk stratification: a pooled analysis. PLoS One 2010; 5: e11488.
39. SIEMERINK MJ, KLAASSEN I, VOGELS IM, GRIFFIOEN AW, Van NOORDEN CJ, SCHLINGEMANN RO: CD34 marks angiogenic tip cells in human vascular endothelial cell cultures. Angiogenesis 2012; 15: 151-63.
40. TOUSOULIS D, ANDREOU I, ANTONIADES C, TENTOLOURIS C, STEFANADIS C: Role of inflammation and oxidative stress in endothelial progenitor cell function and mobilization: therapeutic implications for cardiovascular diseases. Atherosclerosis 2008; 201: 236-47.
41. van WIJK DF, BOEKHOLDT SM, WAREHAM NJ et al.: C-reactive protein, fatal and nonfatal coronary artery disease, stroke, and peripheral artery disease in the prospective EPIC-Norfolk cohort study. Arterioscler Thromb Vasc Biol 2013; 33: 2888-94.
42. VERMA S, KULISZEWSKI MA, LI SH et al.: C-reactive protein attenuates endothelial progenitor cell survival, differentiation, and function: further evidence of a mechanistic link between C-reactive protein and cardiovascular disease. Circulation 2004; 109: 2058-67.
43. FUJII H, LI SH, SZMITKO PE, FEDAK PW, VERMA S: C-reactive protein alters antioxidant defenses and promotes apoptosis in endothelial progenitor cells. Arterioscler Thromb Vasc Biol 2006; 26: 2476-82.
44. AKIRA S, UEMATSU S, TAKEUCHI O: Pathogen recognition and innate immunity. Cell 2006; 124: 783-801.
45. GOH FG, MIDWOOD KS: Intrinsic danger: activation of Toll-like receptors in rheumatoid arthritis. Rheumatology (Oxford) 2012; 51: 7-23.
46. RAICEVIC G, ROUAS R, NAJAR M et al.: Inflammation modifies the pattern and the function of Toll-like receptors expressed by human mesenchymal stromal cells. Hum Immunol 2010; 71: 235-44.
47. ZHOU PH, LIU SQ, PENG H: The effect of hyaluronic acid on IL-1beta-induced chondrocyte apoptosis in a rat model of osteoarthritis. J Orthop Res 2008; 26: 1643-8.
48. ITO C, KUSANO E, AKIMOTO T et al.: Cilostazol enhances IL-1beta-induced NO production and apoptosis in rat vascular smooth muscle via PKA-dependent pathway. Cell Signal 2002; 14: 625-32.
49. CASTEJON R, JIMENEZ-ORTIZ C, VALEROGONZALEZ S, ROSADO S, MELLOR S, YEBRA-BANGO M: Decreased circulating endothelial progenitor cells as an early risk factor of subclinical atherosclerosis in systemic lupus erythematosus. Rheumatology (Oxford) 2014; 53: 631-8.
50. LAURENT S, BOUTOUYRIE P, ASMAR R et al.: Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients. Hypertension 2001; 37: 1236-41.